UC Davis licenses autoimmune patents
Sacramento Business Journal - 1:41 PM PDT Wednesday, May 23, 2007
The University of California has licensed two patents -- one from UC Davis and one from UC Irvine -- to Airmid Inc. for commercialization.
Redwood City-based Airmid has exclusive rights to pursue further testing of the compounds, which could help treat multiple sclerosis and psoriasis.
The agreement was managed by UC Davis InnovationAccess, which aims to license the 841 patents it oversees.